Compare · MDLN vs PDEX
MDLN vs PDEX
Side-by-side comparison of Medline Inc. (MDLN) and Pro-Dex Inc. (PDEX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and PDEX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $42.23B, about 226.9x PDEX ($186.1M).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 4 for PDEX).
- MDLN has more recent analyst coverage (25 ratings vs 0 for PDEX).
- Company
- Medline Inc.
- Pro-Dex Inc.
- Price
- $33.64+4.80%
- $57.78-1.98%
- Market cap
- $42.23B
- $186.1M
- 1M return
- -
- -10.87%
- 1Y return
- -
- +60.08%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 7
- 4
- Recent ratings
- 25
- 0
PDEX
Pro-Dex Inc.
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Latest MDLN
- Medline announces participation in the 2026 Jefferies Global Healthcare Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form 8-K filed by Medline Inc.
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- Large owner Gic Private Ltd sold $274,767,093 worth of shares (7,816,987 units at $35.15) (SEC Form 4)
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- Large owner Gic Private Ltd sold $721,644,227 worth of shares (20,678,630 units at $34.90) (SEC Form 4)
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
Latest PDEX
- Pro-Dex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form 8-K filed by Pro-Dex Inc.
- SEC Form 10-Q filed by Pro-Dex Inc.
- Pro-Dex, Inc. Announces Fiscal 2027 First Quarter Results
- SEC Form DEFA14A filed by Pro-Dex Inc.
- SEC Form DEF 14A filed by Pro-Dex Inc.
- Pro-Dex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Chief Executive Officer Van Kirk Richard Lee Jr sold $45,412 worth of shares (765 units at $59.36) as part of a pre-agreed trading plan, decreasing direct ownership by 0.96% to 79,228 units (SEC Form 4)
- Chief Executive Officer Van Kirk Richard Lee Jr sold $1,165,290 worth of shares (19,235 units at $60.58) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 79,993 units (SEC Form 4)
- Chief Financial Officer Charlton Alisha sold $140,983 worth of shares (2,300 units at $61.30), decreasing direct ownership by 10% to 21,870 units (SEC Form 4)